A Study of the Effectiveness and Safety of Long-acting Injectable Risperidone Versus Placebo in the Treatment of Patients With Schizophrenia
PHASE3CompletedINTERVENTIONAL
Enrollment
458
Participants
Timeline
Start Date
November 30, 1999
Study Completion Date
December 31, 2000
Conditions
SchizophreniaPsychotic Disorders
Interventions
DRUG
risperidone
All Listed Sponsors
lead
Janssen, LP
INDUSTRY
NCT00253136 - A Study of the Effectiveness and Safety of Long-acting Injectable Risperidone Versus Placebo in the Treatment of Patients With Schizophrenia | Biotech Hunter | Biotech Hunter